ARTICLE | Company News
Welichem Biotech, GlaxoSmithKline deal
June 4, 2012 7:00 AM UTC
Welichem granted GlaxoSmithKline's Stiefel Laboratories Inc. subsidiary exclusive rights outside of China, Taiwan, Macau and Hong Kong to develop and commercialize WBI-1001. The product is a topical ...